Banco Bilbao Vizcaya Argentaria, S.A. Bio N Tech Se Transaction History

Banco Bilbao Vizcaya Argentaria, S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	BUY	$98.5 - $125.08 $170,799 - $216,888	1,734 Added 67.68%	4,296 $466,000
Q2 2023 Aug 04, 2023	BUY	$102.58 - $129.66 $62,778 - $79,351	612 Added 31.38%	2,562 $276,000
Q1 2023 May 09, 2023	SELL	$122.57 - $153.67 $8,334 - $10,449	-68 Reduced 3.37%	1,950 $242,000
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $42,279 - $66,419	-357 Reduced 15.03%	2,018 $303,000
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $35,742 - $51,270	-280 Reduced 10.55%	2,375 $323,000
Q2 2022 Aug 08, 2022	BUY	$123.25 - $186.24 $327,228 - $494,467	2,655 New	2,655 $401,000

358

38.4M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $29.6B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Banco Bilbao Vizcaya Argentaria, S.A., based on Form 13F filings with the SEC.

Stay updated on Banco Bilbao Vizcaya Argentaria, S.A. with notifications on news.